ViewRay (VRAY) executive Shah sold 30,364 shares for $2,277 at $0.08
Insider transactions reported
Sanket Shah (executive at ViewRay Inc., VRAY) reported that they sold 30,364 shares for $2,277 at $0.08, and received 350,000 shares between Jul 15, 2023 and Jul 21, 2023. After these transactions the filing shows 386,295 shares held directly.
- Reporting person
- Shah Sanket
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 15, 2023 | Grant or award (A) | Common Stock | +350,000 | - | - | 416,659 direct |
| Jul 21, 2023 | Open-market sale (S) | Common Stock | -30,364 | $0.08 | $2,277 | 386,295 direct |
Holdings before and after
- Common Stock: 66,659 to 386,295 direct
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Shah report in this VRAY Form 4?
Sanket Shah (executive at ViewRay Inc., VRAY) reported that they sold 30,364 shares for $2,277 at $0.08, and received 350,000 shares between Jul 15, 2023 and Jul 21, 2023. After these transactions the filing shows 386,295 shares held directly.
How many VRAY shares does Shah hold after this filing?
The filing shows 386,295 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this VRAY insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for VRAY
Earlier insider filings at VRAY
- Jul 26, 2023SEC Form 4 filed by Podbelski Adam Andrew
- Jul 24, 2023SEC Form 4 filed by Johnson B Kristine
- Jul 21, 2023SEC Form 4 filed by Ebrahimi Farhad Fred
- Jul 21, 2023SEC Form 4 filed by Castelein Caley
- Jul 21, 2023SEC Form 4 filed by Ziegler Paul Jr
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
Follow VRAY and get a push notification the moment its next story breaks.